Skip to Main Content
Try STAT+ TODAY
Trending:
STAT+
Health
Biotech
First Opinion
The Readout

Capitalism v. science & why Clinton weighed opposing Califf

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Oct. 17, 2016

Reprints
The READOUT
Alex Hogan/STAT

The Readout for October 17, 2016

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Vertex, CRISPR Therapeutics inch ahead of rival for genetic…
Vertex, CRISPR Therapeutics inch ahead of rival for genetic fix to sickle cell disease
Drug used to halt puberty in children may cause…
Drug used to halt puberty in children may cause lasting health problems
Experts debate: Are we playing with fire when we…
Experts debate: Are we playing with fire when we edit human genes?
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories